Related Experiment Video
Updated: Jan 15, 2026
Murine Kidney Transplant Technique
Published on: October 20, 2015
Class 1 Indications for Coronary Revascularization Identified in Prekidney Transplant Screening
Avantika Israni1, Bronya L Sandorffy1, Celina S Liu1
1Nephrology Division, Department of Medicine, NYU Grossman School of Medicine, New York, New York.
Insights
Pre-transplant coronary screening rarely identifies significant coronary artery disease requiring intervention in kidney transplant candidates. Routine screening for coronary artery disease (CAD) in these patients is not consistently beneficial.
Area of Science:
- Cardiology
- Nephrology
- Transplant Surgery
Background:
- Cardiovascular disease (CVD) is a leading cause of death in kidney transplant recipients.
- Pre-transplant screening for coronary artery disease (CAD) is common, but its benefit is debated.
- Intervention for CAD is only proven beneficial in complex cases.
Purpose of the Study:
- To systematically review and meta-analyze the frequency of significant coronary artery disease (CAD) detected during pre-kidney transplant screening.
- To determine the prevalence of CAD requiring revascularization based on AHA class 1 indications.
Main Methods:
- Systematic review and meta-analysis of studies published between 1998 and 2024.
- Searched Medline and Embase databases for pre-transplant screening data.
- Primary endpoints: >50% left main stenosis or multi-vessel disease with ejection fraction <35%.
Main Results:
- 44 studies including 1273 identified papers were analyzed.
- Prevalence of AHA class 1 indications for revascularization was low (mean 2%, range 0-17%).
- Prevalence of proximal LAD disease was 2%, left main stenosis 1%, and multi-vessel disease 10%; 35% underwent angiography.
Conclusions:
- Identification of class I indications for revascularization during pre-transplant coronary screening is rare.
- The utility of routine screening for significant CAD in kidney transplant candidates requires further evaluation.
Key Points:
Coronary artery disease is a barrier to kidney transplantation. Many transplant programs mandate routine coronary artery disease screening. It remains unclear how many patients meet class 1 indication for revascularization. We conducted a meta-analysis to estimate the prevalence. Despite high frequency of screening, we found a relatively low prevalence of class 1 indication for coronary revascularization.
Background:
Cardiovascular disease is the most common cause of morbidity and mortality in kidney transplant recipients. Screening for coronary disease is frequently required before kidney transplantation, but coronary intervention has not been shown to be beneficial except in complex coronary artery disease. The likelihood of finding significant coronary artery disease and the benefits of routine pretransplant screening are uncertain.
Methods:
We performed a systematic review and meta-analysis. Medical Literature Analysis and Retrieval System Online and Excerpta Medica database were searched to identify manuscripts published between 1998 and 2024 reporting the results of pretransplant screening. The primary end points were the frequency of detecting significant coronary lesions for which there are American Heart Association class 1 indications for revascularization: ( 1 ) >50% left main stenosis or ( 2 ) multivessel disease with ejection fraction <35% during prekidney transplant screening. Secondary end points included frequency of detecting multivessel disease, proximal left anterior descending artery disease, and number of patients who underwent invasive coronary angiography. Meta-regression was used to explore outcome heterogeneity according to the presence of hypertension, diabetes, and age.
Results:
We identified 1273 studies, out of which 44 met eligibility criteria. The mean prevalence of class 1 indications was 2%, although the heterogeneity was high with estimates ranging from 0% to 17%. Estimated prevalence of proximal left anterior descending disease was 2% and left main stenosis was 1%, whereas 10% of patients had multivessel coronary artery disease, and 35% were referred for invasive angiography. There was no evidence of significant heterogeneity according to sex of the population or prevalence of diabetes or hypertension.
Conclusions:
Identification of class 1 indications for revascularization during pretransplant coronary screening was rare.
Podcast:
This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/JASN/2026_01_08_ASN0000000890.mp3.
Related Concept Videos
01:28Kidney Transplant I: Introduction
01:26Kidney Transplant II: Surgical Procedure
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
01:16Kidney Transplant III: Nursing Management
01:28Cardiac Catheterization I: Pre-Procedure Overview
01:25Chronic Kidney Disease I: Introduction